In December, India Inc reported continued progress in capacity utilisation and revenue, but high management costs and poor demand are still sore points for companies. Industry lobby FICCI and Dhruva Advisors published a survey showing these conclusions. The promise of a Covid-19 vaccine, continuing government and RBI assistance,
and the anticipated advantages of a changing global supply chain have boosted market sentiment.
